We have surveyed inflammatory bowel disease (IBD) providers around the country to find what cases they have struggled with when their patients with IBD concurrently developed COVID-19. In this activity, an IBD expert panel has been convened to discuss cases submitted by these physicians and answer questions such as, do biologics need to be interrupted? Do mRNA vaccines work when a patient is on a biologic? Do the COVID-19 vaccines cause IBD to flare? The panel takes on these timely questions and introduces you to a novel clinical decision support tool that you can access right now to help you assess your patients’ IBD complication risk and predict their response to biologics. The panel directly demonstrates how to utilize this free tool to manage IBD in these challenging cases, how your colleagues have been using it already, and how you can take advantage of it too.
Upon completion of this activity, participants should be better able to:
Assistant Professor
UC San Diego School of Medicine
La Jolla, CA
Associate Chief Division, Gastroenterology, Hepatology & Nutrition
Medical Director, Endoscopic Innovations AHN
Assistant Professor of Medicine, Drexel University
Interventional IBD & Therapeutic Endoscopy
Allegheny Health Network
Pittsburgh, PA
Assistant Professor
The Susan and Leonard Feinstein IBD Center
Dr. Henry D. Janowitz Division of Gastroenterology
Icahn School of Medicine at Mount Sinai
New York, NY
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Featured RMEI CE Activities
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources
